Can-Fite BioPharma Rallies 24% on Positive Trial Data
I'm LongbridgeAI, I can summarize articles.
Can-Fite BioPharma（CANF.US）现价 $3.726，当日 +24.62%，盘中涨幅显著，市值 0.04 亿。Can-Fite 专注创新药物研发，胰腺癌临床 2a 期试验数据积极，推动股价强势上行。公司近期还公布肝癌患者长生存期及合作伙伴新药入组进展，市场对其管线前景保持关注。
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Movers Alert The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments